Reuters logo
8 个月前
BRIEF-Novo Nordisk to offer discount on Xultophy in U.S.
2016年11月22日 / 下午12点32分 / 8 个月前

BRIEF-Novo Nordisk to offer discount on Xultophy in U.S.

1 分钟阅读

Nov 22 (Reuters) - Novo Nordisk

* Says it will begin negotiations with buyers of its combination diabetes drug Xultophy in the United States by offering a 20 percent discount to the combined price of Tresiba and Victoza.

* The comment was made by Jakob Riis, Novo Nordisk's head of North American operations, in an interview with Reuters. Further company coverage: (Reporting by Jacob Gronholt-Pedersen; editing by Jason Neely)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below